Senores Pharmaceuticals gets marketing authorizations for 10 products

05 Dec 2025 Evaluate

Senores Pharmaceuticals has received marketing authorizations from the Philippine Food and Drug Administration (FDA) for a basket of 10 products across Therapies like Cardiovascular, CNS, and Pain management, etc. This milestone marks a significant step in the company’s strategy to expand its footprint in Southeast Asia and enhance access to affordable healthcare.

The approvals provide Senores Pharmaceuticals with a strong platform to serve the Philippines. The market size of these particular drugs in the Philippines is valued at $23 million, underscoring the immense opportunity for growth and patient impact. With these regulatory endorsements, strong manufacturing capabilities, Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region, leveraging its expertise, global partnerships, and uncompromising quality standards to improve treatment outcomes and broaden patient access.

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.

Senores Pharmaceutic Share Price

777.40 -6.85 (-0.87%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×